Rifampicin-Induced Concomitant Renal Injury and Hepatitis

Adverse drug reactions are not unusual during Anti-Tubercular Therapy (ATT). One of the common complications of anti-tubercular treatment is drug induced hepatitis and renal insufficiency has also been reported. Renal failure and/or hepatitis encountered during treatment of tuberculosis can have v...

Full description

Bibliographic Details
Main Authors: Bharti Chogtu, Vyshak Uddur Surendra, Rahul Magazine, Preetam Rajgopal Acharya, Devesh Bhaskar Yerrapragada
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2016-09-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/8578/21030_CE[Ra]_F(P)_PF1(ASEKAK)_PFA(AK).pdf
_version_ 1818162966114074624
author Bharti Chogtu
Vyshak Uddur Surendra
Rahul Magazine
Preetam Rajgopal Acharya
Devesh Bhaskar Yerrapragada
author_facet Bharti Chogtu
Vyshak Uddur Surendra
Rahul Magazine
Preetam Rajgopal Acharya
Devesh Bhaskar Yerrapragada
author_sort Bharti Chogtu
collection DOAJ
description Adverse drug reactions are not unusual during Anti-Tubercular Therapy (ATT). One of the common complications of anti-tubercular treatment is drug induced hepatitis and renal insufficiency has also been reported. Renal failure and/or hepatitis encountered during treatment of tuberculosis can have varied aetiologies: drug induced, concomitant viral infection, pre-existing co-morbidities or a combination of these. Since, hepatitis and/or renal insufficiency can be life threatening a prompt diagnosis is warranted, where drugs should be kept as one of the important cause. Identifying the drug helps in treating hepatitis and/or renal insufficiency along with helping the physician to change the combination of ATT regimen. Rifampicin is one of the most important first line drugs in the treatment of tuberculosis. Hepatitis, epigastric distress, anaemia, thrombocytopenia, and interstitial nephritis are reported adverse drug reactions to rifampicin. As per literature rifampicin induced renal toxicity is usually seen on rifampicin re-exposure, or rifampicin administration on alternate days, both being present in this case. Here we are reporting a case of ATT induced renal failure with concomitant hepatitis where rifampicin was suspected to be the cause.
first_indexed 2024-12-11T16:42:03Z
format Article
id doaj.art-ffb723d06ae24487b1b282ab2fe71c7e
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-12-11T16:42:03Z
publishDate 2016-09-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-ffb723d06ae24487b1b282ab2fe71c7e2022-12-22T00:58:18ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2016-09-01109OD18OD1910.7860/JCDR/2016/21030.8578Rifampicin-Induced Concomitant Renal Injury and HepatitisBharti Chogtu0Vyshak Uddur Surendra1Rahul Magazine2Preetam Rajgopal Acharya3Devesh Bhaskar Yerrapragada4Associate Professor, Department of Pharmacology, Kasturba Medical College, Manipal University, Manipal, Karnataka, India.Postgraduate Student, Department of Pulmonary Medicine, Kasturba Medical College, Manipal University, Manipal, Karnataka, India.Professor, Department of Pulmonary Medicine, Kasturba Medical College, Manipal University, Manipal, Karnataka, India.Associate Professor, Department of Pulmonary Medicine, Kasturba Medical College, Mangalore, Manipal University, Karnataka, India.Student, Kasturba Medical College, Manipal University, Manipal, Karnataka, India.Adverse drug reactions are not unusual during Anti-Tubercular Therapy (ATT). One of the common complications of anti-tubercular treatment is drug induced hepatitis and renal insufficiency has also been reported. Renal failure and/or hepatitis encountered during treatment of tuberculosis can have varied aetiologies: drug induced, concomitant viral infection, pre-existing co-morbidities or a combination of these. Since, hepatitis and/or renal insufficiency can be life threatening a prompt diagnosis is warranted, where drugs should be kept as one of the important cause. Identifying the drug helps in treating hepatitis and/or renal insufficiency along with helping the physician to change the combination of ATT regimen. Rifampicin is one of the most important first line drugs in the treatment of tuberculosis. Hepatitis, epigastric distress, anaemia, thrombocytopenia, and interstitial nephritis are reported adverse drug reactions to rifampicin. As per literature rifampicin induced renal toxicity is usually seen on rifampicin re-exposure, or rifampicin administration on alternate days, both being present in this case. Here we are reporting a case of ATT induced renal failure with concomitant hepatitis where rifampicin was suspected to be the cause.https://jcdr.net/articles/PDF/8578/21030_CE[Ra]_F(P)_PF1(ASEKAK)_PFA(AK).pdfanti tubercular drugsliver function testsserum creatinineserum urea
spellingShingle Bharti Chogtu
Vyshak Uddur Surendra
Rahul Magazine
Preetam Rajgopal Acharya
Devesh Bhaskar Yerrapragada
Rifampicin-Induced Concomitant Renal Injury and Hepatitis
Journal of Clinical and Diagnostic Research
anti tubercular drugs
liver function tests
serum creatinine
serum urea
title Rifampicin-Induced Concomitant Renal Injury and Hepatitis
title_full Rifampicin-Induced Concomitant Renal Injury and Hepatitis
title_fullStr Rifampicin-Induced Concomitant Renal Injury and Hepatitis
title_full_unstemmed Rifampicin-Induced Concomitant Renal Injury and Hepatitis
title_short Rifampicin-Induced Concomitant Renal Injury and Hepatitis
title_sort rifampicin induced concomitant renal injury and hepatitis
topic anti tubercular drugs
liver function tests
serum creatinine
serum urea
url https://jcdr.net/articles/PDF/8578/21030_CE[Ra]_F(P)_PF1(ASEKAK)_PFA(AK).pdf
work_keys_str_mv AT bhartichogtu rifampicininducedconcomitantrenalinjuryandhepatitis
AT vyshakuddursurendra rifampicininducedconcomitantrenalinjuryandhepatitis
AT rahulmagazine rifampicininducedconcomitantrenalinjuryandhepatitis
AT preetamrajgopalacharya rifampicininducedconcomitantrenalinjuryandhepatitis
AT deveshbhaskaryerrapragada rifampicininducedconcomitantrenalinjuryandhepatitis